RxDoctor Payments Data

Alessandro Speciale, MD

Orthopaedic Surgery of the Spine · Annapolis, MDNPI 1962404137

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $27,250 of the $38,933 with a category attached, or 70.0%. 13 manufacturers reported payments, led by Stryker at 52.6% of the total. Reporting peaked in 2021 at $19,647 and has fallen 88.2% since, to $2,313 in 2025.

$38,933in general payments, 2019–2025

Across 114 payments — averaging $341.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$20K
  • Globus Medical$12K
  • Medtronic$6K
  • Si-bone, Inc.$191
  • Johnson & Johnson$154
  • Native Surgical, LLC$109
  • plus $272 from 7 others
$157,974in research payments, 2019–2025

Across 10 payments — averaging $15,797 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$155K
  • Elutia, Inc.$3K

What the payments were for

  • Royalty or licence$1971%
  • Consulting fees$27,25070%
  • Speaking & faculty fees$1,8005%
  • Travel & lodging$6,09116%
  • Food & beverage$3,5949%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker24$20,465
Globus Medical(2 entities)18$11,829
Medtronic(2 entities)51$5,914
Si-bone, Inc.4$191
Johnson & Johnson4$154
Native Surgical, LLC1$109
Orthofix Medical, Inc.3$95
Boston Scientific2$49
Supreme Orthopedic Systems, LLC2$41
Cerapedics Inc.1$23
Biocomposites Inc2$23
Zimmer Biomet1$22
Amgen1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,933 in reported general payments places this provider in the 75th percentile of 49 orthopaedic surgery of the spine providers in Maryland.

See all orthopaedic surgery of the spine providers in Maryland

Medicare billing

Part B allowed, 2024
$500,155
Medicare patients
888
Services billed
2,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin94$677
Gabapentin34$303
Oxycodone Hcl23$87
Prednisone28$81
Meloxicam15$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →